-
Company Insights
NewBlock – Competitor Profile
Block (formerly Square) is a US-based payment services provider that was launched in 2009. Effective from December 10, 2021, Square changed its legal name to Block. However, the company continues to offer its merchant services under the Square brand name, enabling businesses to accept payments through methods including debit and credit cards issued by all major scheme providers, as well as NFC-based solutions such as Google Pay and Apple Pay. For offline payments, the company offers an array of traditional...
-
Sector Analysis
NewNew Drug Approvals and Their Contract Manufacture – 2024 Edition
This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called "CMO Scorecard") is critical for benchmarking the performance of the contract manufacturing organization (CMO) industry and the relative performance of major CMOs. This year's edition includes a discussion of how inflation and increasing global conflict has impacted pharma manufacturers.
-
Product Insights
Api Power Parwanipur Solar PV Park
Api Power Parwanipur Solar PV Park is a solar PV project located in Janakpur, Nepal. The project is owned and being developed by Api Power Co Pvt Ltd. The project is at the financing stage. Empower your strategies with our Api Power Parwanipur Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Abiraterone Acetate in Hormone-Sensitive Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Abiraterone Acetate in Hormone-Sensitive Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Abiraterone Acetate in Hormone-Sensitive Prostate Cancer Drug Details: Abiraterone acetate...
-
Company Insights
Innovation and Patenting activity of APi Group Corp Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of APi Group Corp Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Analyst Opinions
Key Payments Trends for 2024
Exploring trends and insights from the ‘Payments Trends’ report will help you: Identify the top trends impacting the payment industry - mobile payments, social commerce, alternative solutions, AI, open banking, and blockchain. Analyze the leading trends in the industry and learn how they provide fast and frictionless user experiences. Understand each trend in detail to gain a competitive advantage in the market. Identify factors driving the growth of the payments landscape, including super apps, mobile payments, and blockchain. Understand the...
-
Product Insights
Nephrotic Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Nephrotic Syndrome - Drugs In Development, 2023’, provides an overview of the Nephrotic Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Nephrotic Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Thematic Analysis
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 – Top Themes and Predictions – Thematic Intelligence
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 Theme and Predictions Report Overview Total M&A deal value in the technology, media, and telecom (TMT) sector declined 46% in 2023, compared to the previous year. Software and services accounted for over 48% share of the total M&A deal value in 2023. The ‘Global Tech, Media, And Telecom (TMT) M&A Deals 2023 Theme and Predictions Report’ analyzes the top disruptive themes that drove M&A activity in the technology, media, and telecom (TMT)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GUR-701 in Androgenic Alopecia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GUR-701 in Androgenic Alopecia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GUR-701 in Androgenic Alopecia Drug Details: GUR-701 is under development for the...